{"id":"https://openalex.org/W4416385019","doi":"https://doi.org/10.7759/cureus.97252","title":"Concurrent Use of Anifrolumab and Belimumab in a Patient With Systemic Lupus Erythematosus Presenting With Recurrent Severe Cutaneous Involvement and Lupus Nephritis","display_name":"Concurrent Use of Anifrolumab and Belimumab in a Patient With Systemic Lupus Erythematosus Presenting With Recurrent Severe Cutaneous Involvement and Lupus Nephritis","publication_year":2025,"publication_date":"2025-11-19","ids":{"openalex":"https://openalex.org/W4416385019","doi":"https://doi.org/10.7759/cureus.97252","pmid":"https://pubmed.ncbi.nlm.nih.gov/41426928","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12716614"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.97252","doi":"https://doi.org/10.7759/cureus.97252","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.97252","pdf_url":"https://www.cureus.com/articles/430820-concurrent-use-of-anifrolumab-and-belimumab-in-a-patient-with-systemic-lupus-erythematosus-presenting-with-recurrent-severe-cutaneous-involvement-and-lupus-nephritis.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/430820-concurrent-use-of-anifrolumab-and-belimumab-in-a-patient-with-systemic-lupus-erythematosus-presenting-with-recurrent-severe-cutaneous-involvement-and-lupus-nephritis.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054835523","display_name":"Mar\u00eda Dolores Manj\u00f3n Rodr\u00edguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117781","display_name":"Complejo Hospitalario de Ja\u00e9n","ror":"https://ror.org/02ecxgj38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210117781"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Dolores Manj\u00f3n-Rodr\u00edguez","raw_affiliation_strings":["Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP","institution_ids":["https://openalex.org/I4210117781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022818817","display_name":"Francisco Jos\u00e9 Borrego Utiel","orcid":"https://orcid.org/0000-0001-8861-3132","observed_orcids":["https://orcid.org/0000-0001-8861-3132"]},"institutions":[{"id":"https://openalex.org/I4210117781","display_name":"Complejo Hospitalario de Ja\u00e9n","ror":"https://ror.org/02ecxgj38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210117781"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Francisco J Borrego-Utiel","raw_affiliation_strings":["Nephrology, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP","institution_ids":["https://openalex.org/I4210117781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111429994","display_name":"Enoc Merino Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117781","display_name":"Complejo Hospitalario de Ja\u00e9n","ror":"https://ror.org/02ecxgj38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210117781"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enoc Merino-Garc\u00eda","raw_affiliation_strings":["Nephrology, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP","institution_ids":["https://openalex.org/I4210117781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125537636","display_name":"Alba Gil Morillas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117781","display_name":"Complejo Hospitalario de Ja\u00e9n","ror":"https://ror.org/02ecxgj38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210117781"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alba Gil-Morillas","raw_affiliation_strings":["Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP","institution_ids":["https://openalex.org/I4210117781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050245406","display_name":"Agust\u00edn Colodro Ruiz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117781","display_name":"Complejo Hospitalario de Ja\u00e9n","ror":"https://ror.org/02ecxgj38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210117781"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Agust\u00edn Colodro-Ruiz","raw_affiliation_strings":["Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, ESP","institution_ids":["https://openalex.org/I4210117781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5022818817"],"corresponding_institution_ids":["https://openalex.org/I4210117781"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.37666393,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"11","first_page":"e97252","last_page":"e97252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.972000002861023},{"id":"https://openalex.org/keywords/anifrolumab","display_name":"anifrolumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":1.0},{"id":"https://openalex.org/keywords/combination-biologic-therapy","display_name":"combination biologic therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cutaneous-lupus-erythematosus","display_name":"cutaneous lupus erythematosus","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/facial-lesions","display_name":"facial skin lesions","score":0.48399999737739563},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.6269999742507935},{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.9919999837875366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9672999978065491},{"id":"https://openalex.org/C2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","level":3,"score":0.7746999859809875},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5755000114440918},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.557200014591217},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5041999816894531},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.48730000853538513},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4551999866962433},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4542999863624573},{"id":"https://openalex.org/C2777058396","wikidata":"https://www.wikidata.org/wiki/Q401402","display_name":"Nephritis","level":2,"score":0.3662000000476837},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.3465000092983246},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.33489999175071716},{"id":"https://openalex.org/C2776874634","wikidata":"https://www.wikidata.org/wiki/Q582207","display_name":"Antiphospholipid syndrome","level":3,"score":0.3312000036239624},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3084000051021576},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.28769999742507935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2856999933719635},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2685999870300293},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.2635999917984009},{"id":"https://openalex.org/C2779123688","wikidata":"https://www.wikidata.org/wiki/Q421094","display_name":"Hydroxychloroquine","level":5,"score":0.25440001487731934}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.97252","doi":"https://doi.org/10.7759/cureus.97252","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.97252","pdf_url":"https://www.cureus.com/articles/430820-concurrent-use-of-anifrolumab-and-belimumab-in-a-patient-with-systemic-lupus-erythematosus-presenting-with-recurrent-severe-cutaneous-involvement-and-lupus-nephritis.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:41426928","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41426928","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:12716614","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12716614/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.7759/cureus.97252","doi":"https://doi.org/10.7759/cureus.97252","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.97252","pdf_url":"https://www.cureus.com/articles/430820-concurrent-use-of-anifrolumab-and-belimumab-in-a-patient-with-systemic-lupus-erythematosus-presenting-with-recurrent-severe-cutaneous-involvement-and-lupus-nephritis.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416385019.pdf","grobid_xml":"https://content.openalex.org/works/W4416385019.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2605213569","https://openalex.org/W2891788869","https://openalex.org/W3037001122","https://openalex.org/W3085025551","https://openalex.org/W3092324881","https://openalex.org/W3204257182","https://openalex.org/W4211012592","https://openalex.org/W4211168185","https://openalex.org/W4221000769","https://openalex.org/W4221106889","https://openalex.org/W4281634068","https://openalex.org/W4281922547","https://openalex.org/W4293741145","https://openalex.org/W4353015957","https://openalex.org/W4364377581","https://openalex.org/W4378573658","https://openalex.org/W4388452008","https://openalex.org/W4389979559","https://openalex.org/W4390840280","https://openalex.org/W4400382836","https://openalex.org/W4401317278","https://openalex.org/W4403298726"],"related_works":["https://openalex.org/W4403035549","https://openalex.org/W7138877703","https://openalex.org/W7154071854","https://openalex.org/W7164011664","https://openalex.org/W4378573658","https://openalex.org/W4283016883","https://openalex.org/W7118278944","https://openalex.org/W4397023601","https://openalex.org/W4417035926","https://openalex.org/W7106793792"],"abstract_inverted_index":{"Anifrolumab":[0,16],"and":[1,41,92,161,170],"belimumab":[2,96,171],"are":[3],"two":[4],"biologic":[5,73,138],"agents":[6,139,174],"extensively":[7],"employed":[8],"in":[9,21,26,37,47,63,104,119,150,155,178],"patients":[10],"with":[11,95,116,158],"systemic":[12],"lupus":[13,89,132,185],"erythematosus":[14],"(SLE).":[15],"has":[17,33],"demonstrated":[18],"pronounced":[19],"efficacy":[20],"reducing":[22],"cutaneous":[23,110,160],"inflammatory":[24,80],"activity":[25],"cases":[27,157],"refractory":[28],"to":[29,67,86,102,147,168,180],"other":[30],"therapies.":[31,74],"Belimumab":[32],"exhibited":[34],"clinical":[35],"effectiveness":[36],"ameliorating":[38],"articular":[39],"symptoms":[40],"renal":[42,105,162],"involvement,":[43],"as":[44,46],"well":[45],"decreasing":[48],"the":[49,64,68,123,131,173],"occurrence":[50],"of":[51,71,99,109,122,130,184],"new":[52],"disease":[53],"flares.":[54],"The":[55,75],"case":[56],"presented":[57],"here":[58],"constitutes":[59],"a":[60],"singular":[61],"report":[62],"literature":[65],"owing":[66],"combined":[69],"use":[70],"both":[72],"patient":[76],"initially":[77],"developed":[78,91],"intense":[79],"facial":[81],"lesions,":[82,111],"which":[83],"responded":[84],"completely":[85],"anifrolumab.":[87],"Thereafter,":[88],"nephritis":[90],"was":[93,113],"managed":[94],"following":[97],"cessation":[98],"anifrolumab,":[100],"leading":[101],"improvement":[103],"parameters.":[106],"Upon":[107],"reactivation":[108],"anifrolumab":[112,169],"reinstated":[114],"concomitantly":[115],"belimumab,":[117],"resulting":[118],"full":[120],"resolution":[121],"skin":[124],"lesions":[125],"while":[126],"preserving":[127],"complete":[128],"remission":[129],"nephritis.":[133],"We":[134,152],"discuss":[135],"how":[136],"various":[137],"can":[140],"act":[141],"on":[142],"separate":[143],"pathogenic":[144],"pathways":[145],"contributing":[146],"organ":[148],"involvement":[149,163],"SLE.":[151],"suggest":[153],"that":[154,164],"some":[156],"severe":[159],"do":[165],"not":[166],"respond":[167],"individually,":[172],"may":[175],"be":[176],"used":[177],"combination":[179],"achieve":[181],"adequate":[182],"control":[183],"disease.":[186]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-19T00:00:00"}